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Objective: To determine the cumulative oxytocin dose needed to achieve vaginal delivery among obese and non-
obese women.Methods: A retrospective study was undertaken of womenwith singleton, term (≥37 weeks) preg-
nancieswho delivered at an institution in California, USA, betweenMay 1 and July 31, 2012.Womenwere deemed
to be obesewhen their bodymass index (BMI; calculated asweight in kilograms divided by the square of height in
meters) was 30 or above. Cumulative oxytocin doses were calculated for women who achieved vaginal delivery.
Results: Overall, 413 women were included. Among 357 women for whom BMI data were available, 204 (57.1%)
were obese. Vaginal deliverywas achieved in 379women. Amongwomenwho received augmentation after spon-
taneous labor onset, obese women trended towards more cumulative oxytocin (minimum: 24.7 ± 100.5 mU
among women with a BMI of 18.50–24.99; maximum: 1580.5 ± 2530.5 mU among women with a BMI of
35.00–39.99; P=0.086).Womenwho underwent induction of labor required signiﬁcantlymore oxytocinwith in-
creasing BMI class (P b 0.001), despite no difference in length of labor. Conclusion:Obese women required a larger
cumulative oxytocin dose to achieve vaginal birth during labor induction, but not during augmentation of labor.
The physiology of spontaneous labor could supersede or inﬂuence the metabolic derangement facing obese pa-
tients undergoing induction of labor.
© 2015 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Obesity is a risk factor for cesarean delivery: with increasingweight,
the odds of a cesarean delivery can more than double [1–3]. Contempo-
rary analyses suggest that a protracted ﬁrst stage of labor is more com-
mon among obese women than amongwomen of a normal weight, and
that the second stage of labor progresses more slowly [4–8]. The aver-
age progress during labor in obese women can be interpreted as a
labor arrest disorder, which is one of the major contributing indications
for preventable primary cesarean in the USA [9–11].
The reasons behind the slower progress in labor among obese
women remain unknown. Increasing evidence suggests that a complex
interplay of hormonal modulators produced in adipose tissue could in-
hibit myometrial contractility [12–14]. In vitro studies also suggest that
oxytocin receptor expression and/or function is affected by body mass
index (BMI, calculated as weight in kilograms divided by the square of
height in meters) and that oxytocin response is somehow blunted byFetal Medicine, Department of
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Valenzuela).
logy and Obstetrics. Published byobesity [15]. Indeed, treatment of protracted labor with oxytocin has
been shown to be less effective in obese patients [16].
The objective of the present studywas to assess the cumulative oxyto-
cin dose needed to achieve vaginal delivery among obese and non-obese
women after spontaneous onset of labor or labor induction. The low pri-
mary cesarean delivery rate in the study centermakes for an ideal setting
to study the cumulative oxytocin dose required for vaginal birth.2. Materials and methods
A retrospective study was undertaken of women who delivered at
Arrowhead Regional Medical Center (ARMC), Colton, CA, USA, between
May 1 and July 31, 2012. The ARMC performs approximately 2500 deliv-
eries annually and serves as a tertiary referral center for complicated
pregnancies within the County of San Bernardino, CA. Viable singleton
pregnancies at term (37–42 weeks) with cephalic presentation were in-
cluded. Women with a previous cesarean delivery, multiple pregnancy,
or abnormal placentation, and those undergoing primary cesarean deliv-
ery formaternal or fetal indications that would contraindicate vaginal de-
livery (i.e. breech) were excluded. The study was conducted with the
approval of the ARMC Institutional Review Board. Informed consent was
not required or obtained because of the retrospective nature of the study.Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
Table 1
Demographic and perinatal characteristics of all included women.a
Characteristics Value (n = 413)
Age, y 25.24 ± 6.19
Gravidity 2.74 ± 1.85
Parity 1.25 ± 1.48
Ethnic originb
White 30 (9.6)
Hispanic 236 (75.6)
Black 29 (9.3)
Asian 6 (1.9)
Other 11 (3.5)
Length of pregnancy, wk 39.4 ± 1.2
BMI 32.12 ± 6.76
High-risk pregnancy 266 (64.4)
WHO obesity classc
Normal 39 (10.9)
Pre-obese 114 (31.9)
Obese, class I 100 (28.0)
Obese, class II 65 (18.2)
Obese, class III 39 (10.9)
Admission cervix examination
Cervix dilation 2.79 ± 1.91
Cervix effacement 67.05 ± 25.86
Fetal station –1.5 ± 0.9
Bishop score (modiﬁed) 5.27 ± 1.84
Oxytocin
No 151 (36.6)
Yes 262 (63.4)
Type of delivery
Spontaneous vaginal 360 (87.2)
Operative vaginal 19 (4.6)
Cesarean 34 (8.2)
Neonatal characteristics
Birth weight, g 3332 ± 419
5-minute Apgar score 8.92 ± 0.36
Umbilical artery pH 7.26 ± 0.07
Abbreviation: BMI, body mass index (calculated as weight in kilograms divided by
the square of height in meters).
a Values are given as mean ± SD or number (percentage).
b n = 312.
c n = 357.
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at time of delivery, method of delivery, use of oxytocin (as augmen-
tation [among women with spontaneous onset of labor] compared
with induction), age, gravidity, parity, gestational age, birth weight,
Apgar score, umbilical cord arterial pH, cervical examination at
time of admission, maternal medical comorbidities, indication for
induction, and cumulative oxytocin dose. BMI was calculated based
on delivery weight and height, as pre-pregnancy weight is per-
formed by recall and subject to a greater degree of bias. Pregnancies
were classiﬁed as high risk when the mother had one or more
signiﬁcant comorbid condition that could increase the odds of
cesarean delivery, including diabetes (gestational or pre-existing),
intrauterine growth restriction, hypertension, pre-eclampsia,
anemia (hemoglobin b100 g/L), asthma, use of illicit substances,
infections with herpes simplex virus, heart disease, hospitalization
during pregnancy, lupus, seizure disorder, advanced maternal age
(age 35 years or greater at time of delivery), or other maternal or
fetal condition. The WHO International Classiﬁcation of Obesity
was used to deﬁne ﬁve BMI classes: normal weight (18.50–24.99),
pre-obese (25.00–29.99), obesity class I (30.00–34.99), obesity
class II (35.00–39.99), and obesity class III (≥40.00). Spontaneous
labor was deﬁned by regular uterine contractions with cervical
dilation of 3 cm or more on digital examination, irrespective of
effacement, or documented cervical change in the presence of
uterine contractions if cervical dilation was less than 3 cm.
Oxytocin augmentationwas started under the direction of the on-call
attending physician if inadequate contractionswere present (b4 contrac-
tions in a 10-minute period or b200Montevideo units [MVU])with a lack
of cervical dilation or fetal descent, after the onset of spontaneous labor.
The ARMC standard practice in patients with an arrest of labor follows
evaluation of estimated fetal weight and clinical pelvimetry, placement
of internal monitors if not contraindicated, and oxytocin infusion to
treat inadequate contractions, aiming for 200–250 MVU. Thus, for labor
augmentation, oxytocin was started at a rate of 1–2 mU per minute and
increased by 1–2 mU per minute every 20–30 minutes. For labor induc-
tion, cervical ripening was performed at the discretion of the attending
physician using 25–50 μg misoprostol by oral or vaginal route every
4–6 hours, transcervical Foley bulb ripening, oxytocin according to the
labor augmentation titration schedule, or through a sequential combina-
tion of methods. Oxytocin was started following cervical ripening at the
discretion of the attending physician. A minimum of 4 hours since miso-
prostol administration was required before oxytocin initiation. If
transcervical ripening was used, oxytocin administration was started
after expulsion of the catheter.
Comparisonsweremade between four subgroupswithin the cohort,
deﬁned as: BMI below 30, spontaneous labor; BMI of 30 or above, spon-
taneous labor; BMI below30, induction of labor; and BMI of 30 or above,
induction of labor. Perinatal characteristics between the four groups
were compared using the Student t test and χ2 test as appropriate. The
Levene test for equality of variances was used to determine use of the
t test for equal or unequal variances. The Fisher exact test was used to
compare the frequency of high-risk pregnancies, and use of oxytocin
among induced patients.
Cumulative oxytocin doses were compared in augmented patients
and in those who underwent induction of labor on the basis of BMI
class using univariate ANOVA testing. One outlier, with a BMI of 36.2,
was excluded from the analysis because the cumulative oxytocin dose
was extremely high (675,000 mU). Least-square difference testing
was used to compare the ﬁve BMI classes. Only women who achieved
vaginal delivery were included in the analysis of cumulative oxytocin
dose, because cesarean delivery for either failure to progress or category
2/3 fetal heart rate tracing interrupted the exposure and falsely de-
creased the cumulative doses.
Initial cervical examinationswere also compared for the four groups
using a modiﬁcation of the Bishop score. Position and consistency were
not reliably recorded in the medical record; therefore, dilation,effacement, and station were used to create a score ranging from 0 to
a maximum of 9.
The duration of labor was determined to assess whether any in-
creased oxytocin dose was due to a longer labor, and therefore a longer
duration of exposure to oxytocin alone, rather than an increased need
for oxytocin. The ﬁrst and second stages of labor were considered to
be from 6–10 cm dilation and from 10 cm to delivery, respectively.
The total time for active labor was deﬁned as the sum of the ﬁrst and
second stages, or the time from 6 cm to delivery. The duration of labor
was compared for the ﬁrst, second, and active stages for each BMI
class, on the basis of the onset of labor (spontaneous or induction),
using a univariate ANOVA test.
All analyses were performed using SPSS version 22.0.0.0 (IBM,
Armonk, NY, USA). P b 0.05 was considered statistically signiﬁcant.3. Results
In total, 413womenwere included. Among thesewomen, 265 (64.2%)
were admittedwith spontaneous labor and 148 (35.8%) underwent labor
induction. A primary cesarean delivery was performed in 34 (8.2%)
women. Oxytocin was administered to 262 (63.4%) women. Primary
cesarean delivery was more frequent among women who received
oxytocin (31 [11.8%] of 262) than among those who did not receive oxy-
tocin (3 [2.0%] of 151; P= 0.002).
Overall, 204 (57.1%) of 357 women for whom BMI was available
were obese (Table 1). Cesarean delivery was more common among
obese women (21 [10.3%] of 204) than among women with a BMI
below 30 (10 [6.5%] of 153), although the difference was not signiﬁcant
Table 3
Methods of cervical ripening among women who underwent induction.a
Method of cervical ripening BMI b30 (n = 40) BMI ≥30 (n = 61) P value
Misoprostol 22 (55.0) 36 (59.0) 0.798
Misoprostol and Foley catheter 0 1 (1.6)
Foley catheter 2 (5.0) 2 (3.3)
Oxytocin 14 (35.0) 17 (27.9)
Amniotomy 2 (5.5) 5 (8.2)
Abbreviation: BMI, body mass index (calculated as weight in kilograms divided by the
square of height in meters).
a Values are given as number (percentage) unless indicated otherwise.
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mal weight, 8 (7.0%) of 114 in the pre-obese group, 9 (9.0%) of 100 in
obesity class I, 5 (7.7%) of 65 in obesity class II, and 7 (17.9%) of 39 in
obesity class III. In all women, use of oxytocin was more common
among obese women (146 [71.6%] of 204) than among non-obese
women (80 [52.3%] of 153; P= 0.003).
Among women with a spontaneous onset of labor, obese women
were more likely to receive oxytocin augmentation (P = 0.02),
be older (P = 0.037), and have neonates with higher birth weights
(P = 0.004) than were non-obese women, but surprisingly, fewer
were noted to be high risk (P= 0.013) (Table 2). The remaining spon-
taneous labor characteristics analyzed were similar between obese
and non-obese women (Table 2).
With regard to women who underwent labor induction, there were
no notable differences in the demographic and perinatal characteristics
between obese and non-obese women, except for the ﬁndings that
more obese women had received oxytocin (P= 0.036) and that obese
women delivered neonates with a higher birth weight (P = 0.008)
(Table 2). Few obese women achieved labor using ripening methods
alone (Table 3). There was no difference between women with a BMI
below 30 and women with a BMI of 30 or above with regard to the useTable 2
Characteristics among the four subgroups.a
Characteristic Spontaneous onset of laborb
BMI b30 (n = 102) BMI ≥30 (n = 122
Cesarean delivery 4 (3.9) 8 (6.6)
Age, y 24.04 ± 5.69 25.70 ± 6.05
Gravidity 2.66 ± 1.71 3.01 ± 1.94
Parity 1.28 ± 1.35 1.35 ± 1.43
Ethnic origind
White 5/12 (41.7) 7/12 (58.3)
Hispanic 53/127 (41.7) 74/127 (58.3)
Black 11/19 (57.9) 8/19 (42.1)
Asian 5/6 (83.3) 1/6 (16.7)
Other 1/4 (25.0) 3/4 (75.0)
Gestational age, wk 39.1 ± 1.1 39.4 ± 1.1
High-risk pregnancy 82 (80.4) 83 (68.0)
BMI 26.12 ± 2.45 36.88 ± 4.88
WHO obesity class
Normal 28 (27.5) 0
Pre-obese 74 (72.5) 0
Obesity class I 0 61 (50.0)
Obesity class II 0 42 (34.4)
Obesity class III 0 19 (15.6)
Cervix characteristics on admission
Dilation, cm 3.8 ± 1.9 3.4 ± 1.8
Effacement, % 73.7 ± 24.7 74.2 ± 23.3
Fetal statione –1.2 ± 0.9 –1.4 ± 0.9
Bishop score (modiﬁed) 6.1 ± 1.5 5.9 ± 1.5
Oxytocin use
No oxytocin 67 (65.7) 56 45.9)
Oxytocin 35 (34.3) 66 (54.1)
Type of delivery
Spontaneous vaginal 91 (89.2) 110 (90.2)
Operative vaginal 7 (6.9) 4 (3.3)
Cesarean 4 (3.9) 8 (6.6)
Neonatal characteristics
Birth weight, g 3252 ± 376 3415 ± 419
5-minute Apgar score 8.9 ± 0.5 8.9 ± 0.3
Umbilical artery pH 7.28 ± 0.07 7.26 ± 0.07
Length of labor, min
First stage 170.8 ± 140.5 161.3 ± 129.4
Second stage 37.2 ± 45.6 38.5 ± 51.7
Active labor 207.5 ± 160.7 200.2 ± 152.3
Abbreviation: BMI, body mass index (calculated as weight in kilograms divided by the square
a Values are given as number (percentage), mean ± SD, or number/total number (percenta
b Data for BMI missing for 41 women.
c Data for BMI missing for 15 women.
d Data for ethnic origin missing for 69 women.
e –5 to +5
f Fisher exact test.of cervical ripening methods (Table 3). Indications for induction did not
differ between obese and non-obese women (P= 0.99) (Table 4).
Among the34womenwhounderwent cesareandelivery, the indica-
tion was category 2/3 fetal heart rate for 20 (58.8%), failure to progress
for 13 (38.2%), and hemorrhage for 1 (2.9%). Further, the indication for
cesarean delivery did not depend on obesity (P= 0.755).
The mean cumulative oxytocin dose for the 379 women who deliv-
ered vaginally was 2270 ± 4226 mU (range 13–29 972). Among
women who received augmentation, there was a non-statisticallyInduction of laborc
) P value BMI b30 (n = 51) BMI ≥30 (n = 82) P value
0.336 6 (11.8) 14 (17.1) 0.475
0.037 24.29 ± 7.00 26.38 ± 6.96 0.096
0.115 2.33 ± 1.84 2.67 ± 1.92 0.318
0.716 0.88 ± 1.31 1.13 ± 135 0.292
0.300 0.892
7/16 (43.8) 9/16 (56.3)
26/70 (37.1) 44/70 (62.9)
2/8 (25.0) 6/8 (75.0)
0 0
2/4 (50.0) 2/4 (50.0)
0.095 39.6 ± 1.4 39.7 ± 1.4 0.923
0.013 26 (51.0) 34 (41.5) 0.159f
b0.0011 26.93 ± 2.42 37.21 ± 6.70 b0.001
11 (21.6) 0
40 (78.4) 0
0 39 (47.6)
0 23 (28.0)
0 20 (24.4)
0.105 1.4 ± 1.0 1.2 ± 0.9 0.096
0.876 56.3 ± 22.4 51.1 ± 24.5 0.224
0.115 –1.9 ± 0.9 –2.1 ± 0.9 0.171
0.308 3.9 ± 1.4 3.5 ± 1.3 0.114
0.002 6 (11.8) 2 (2.4) 0.036f
45 (88.2) 80 (97.6)
0.336 44 (86.3) 65 (79.3) 0.530
1 (2.0) 4 (4.9)
6 (11.8) 14 (17.1)
0.004 3141 ± 483 3371 ± 439 0.008
0.706 8.9 ± 0.1) 8.9 ± 0.4) 0.058
0.050 7.26 ± 0.06 7.25 ± 0.07 0.181
0.651 181.2 ± 187.7 153.7 ± 144.7 0.440
0.870 52.5 ± 50.6) 47.8 ± 47.5 0.637
0.764 233.7 ± 201.1 201.1 ± 163.9 0.383
of height in meters).
ge), unless indicated otherwise.
Table 4
Indications for induction of labor.a
Indication Total
(n = 134)
BMI b30
(n = 53)
BMI ≥30
(n = 81)
Pre-eclampsia 33 (24.6) 9 (17.0) 24 (29.6)
Post-dates 28 (20.9) 13 (24.5) 15 (18.5)
Oligohydramnios 20 (14.9) 11 (20.8) 9 (11.1)
Maternal medical complication 15 (11.2) 5 (9.4) 10 (12.3)
Rupture of membranes 11 (8.2) 3 (5.7) 8 (9.9)
Diabetes 8 (6.0) 1 (1.9) 7 (8.6)
Non-reassuring fetal status 8 (6.0) 3 (5.7) 5 (6.2)
Intrauterine growth restriction 6 (4.5) 5 (9.4) 1 (1.2)
Vaginal bleeding 2 (1.5) 0 2 (2.5)
Electiveb 3 (2.2) 3 (5.7) 0
Abbreviation: BMI, body mass index (calculated as weight in kilograms divided by the
square of height in meters).
a Values are given as number (percentage).
b Elective induction performed at patient request; ≥39 weeks of pregnancy without
medical or obstetric indication.
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(minimum: 24.7 ± 100.5 mU among women with a normal weight;
maximum: 1580.5 ± 2530.5 mU among women in obesity class II;
P=0.086) (Fig. 1). However, even though therewere no signiﬁcant dif-
ferences in the duration of theﬁrst or second stages of labor, and despite
having a slightly shorter overall length of labor, womenwhounderwent
induction required a signiﬁcantly increased oxytocin dosewith increas-
ing BMI class (P b 0.001; adjusted R2= 0.194). Among inducedwomen,
least-squares difference analysis showed that the cumulative dose be-
tween normal-weight and pre-obese women was not signiﬁcantly dif-
ferent (P = 0.373). However, women of a normal weight required
signiﬁcantly less oxytocin than did women in obesity class I or III
(P= 0.010 and P= 0.020, respectively), with a trend toward less oxy-
tocin use when compared with women in obesity class II (P= 0.054).
Women in the pre-obese group required signiﬁcantly less oxytocin
than didwomen in obesity class III (P=0.047). However, no signiﬁcant
differenceswere recorded betweenwomen in obesity class III and those
in class I (P = 0.792) or class II (P = 0.474). For each step increase in
WHO obesity class, women required between 445 mU (class I to class
II; P= 0.54) and 1494 mU (pre-obese to class I; P= 0.016) more oxy-
tocin. Women in obesity class III required 2489 mU more oxytocin
than did women of a normal weight.WHO BMI Class
Obesity class IIIObesity class IIObesity class IPre-ObesityNormal weight
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b  Non-significant increase in cumulative oxytocin dose (P=0.086)
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Fig. 1. Cumulative oxytocin dose according to WHO obesity class in women who had
spontaneous labor or induction of labor. Abbreviation: BMI, body mass index.4. Discussion
The present results indicate that obese women who undergo induc-
tion of labor require incrementally more cumulative oxytocin as their
BMI class increases; nevertheless, obese women whose spontaneous
labor is augmented do not require more cumulative oxytocin to achieve
vaginal delivery. The indication for induction and starting Bishop scores
were similar for obese and non-obesewomen, suggesting the higher cu-
mulative oxytocin dose is a result of increasedweight. Previous research
on oxytocin use in obese patients has focused on oxytocin requirements
during labor (mU/minute) as opposed to the cumulative doses needed
to achieve vaginal delivery [17,18]. However, the high probability of ce-
sarean delivery—reported to be up to 70% in women in obesity class III
in one review [16]—has impeded the quantiﬁcation of cumulative oxy-
tocin requirements. Because the ARMC has a low cesarean rate and
given that an increased likelihood of cesarean delivery with increasing
BMI classwas not observed in the present study, the resultsmake it pos-
sible to quantify and compare the oxytocin doses required to achieve
vaginal delivery in induced and augmented women by BMI class.
The hormonal milieu of an obese woman appears to interact with
oxytocin regulation and response, and/or affect myometrium contractili-
ty. It is possible that increased BMI leads to variation in expression and
function of the oxytocin receptor of the human myometrium [15],
which explains the higher doses of oxytocin required in obese patients.
Further, leptin, methyl palmitate, and apelin are overexpressed in obese
women, and have all been shown to impact myometrium contractility
[12–14]. The present results showed that, amongwomenwith augment-
ed labor, obesity was not associated with higher oxytocin doses. Perhaps
thephysiology of spontaneous labor supersedes or changes themetabolic
derangement facing the obese patient undergoing induction of labor. This
would also explain previous results indicating a lack of difference in
myometrium contractility in response to oxytocin on the basis of BMI
[19]; as the present results suggest, themyometrium contractility of aug-
mented and induced women could be different. Thus, the impact of BMI
on oxytocin receptor function or upregulation, in the context of known
hormonal variants in obesewomen, in the setting of induction compared
to augmented labor would be an interesting investigation.
The reason for fewer high-risk pregnancies in obese women with
spontaneous labor compared with non-obese women with spontane-
ous labor is unknown, but could reﬂect a difference in the type of
high-risk conditions experienced by women with a BMI below 30 and
thosewhoare obese. Perhaps thenature or severity of thehigh-risk con-
dition in an obese woman predisposes her to spontaneous labor before
an indicated scheduled induction date.
A major strength of the present study is the large proportion of
women whowere obese at a center with a low primary cesarean deliv-
ery rate, which allowed an appropriate assessment of the cumulative
oxytocin dose according toWHO BMI class in womenwith an adequate
opportunity to deliver vaginally. The main limitation of the present re-
view is the lack of an evaluation of other medications used during
labor, such as magnesium sulfate, which can affect labor progression.
Further, given the retrospective nature of this review, it wasnot possible
to control for methods of induction; although the cervix ripening
methods used were similar between obese and non-obese women,
the effect of method of induction on oxytocin use could not be deter-
mined. Additionally, possible complications, such as postpartum hem-
orrhage in women with a higher cumulative oxytocin dose (a known
risk), were not assessed. Finally, a standard low-dose oxytocin protocol
was used; therefore, it is unclear if labor could be achieved more expe-
diently in obese women using higher dose titrations.
The intention of the present study was not to determine the reasons
behind the achievement of a low primary cesarean delivery rate, but in-
stead to take advantage of this fact to quantify the cumulative doses of
oxytocin required to achieve vaginal delivery. For all pregnancies deliv-
ered in the study period at any gestational age, the primary cesarean de-
livery rate was 13% (preterm birth was excluded in the analysis above);
58 K. Roloff et al. / International Journal of Gynecology and Obstetrics 131 (2015) 54–58theUSnational primary cesarean delivery rate ranges from13% to 20.6%
[20,21]. Obesity was not a risk factor for cesarean delivery at ARMC dur-
ing the study period. Despite delivering neonates with a higher mean
birthweight, 90% of obesewomenwere able to achieve vaginal delivery
in the same average time as the non-obese cohort.
A very low primary cesarean delivery can be obtained in part by
attaining adequate labor during induction, which could entail increased
cumulative doses of oxytocin as BMI increases. Obesewomen required a
larger cumulative oxytocin doses to achieve vaginal birth during labor
induction. Nevertheless, higher oxytocin doses were not required for
obese women when their labor was augmented.
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